Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,146.40
(
-0.40%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
96.00
(
1.22%
)
Bitcoin
71,135.09
(
0.01%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: None

Friday, 01/17/2014 7:46:46 PM

Friday, January 17, 2014 7:46:46 PM

Post# of 347009
GTC Novel Immunotherapeutics Summit 2014- Jan 30
Speaker: Bruce Freimark, PhD, Phosphatidylserine Targeting Antibodies Enhances Activity of Immune Checkpoint Inhibitors and Re-activates Immune System in Tumors

Nice to see that the events/presentations page updated.

http://ir.peregrineinc.com/events.cfm

----------------------------------------------------------------

CJ's previous post of upcoming known events....

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=95699423

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote